Delivery Order SPE2DB24D6038-SPE2DB25FEMNJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Propranolol ER 80 mg capsules (1,000 count) valued at $1,122.92. This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by September 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a contract value of $6,630.72 and an ultimate completion date of July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support...
- The Defense Logistics Agency awarded a $6,074.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 160 mg capsules (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded and represents a discrete delivery order issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a ceiling value of $2,301.91. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4557724257 - Propranolol ER 60 mg capsules in 100s. The firm-fixed-price contract has a ceiling value of $2,748.21 and an ultimate completion date of July 7, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,695.28 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the delivery of 4,561,317,576 units of the medication Propranolol ER 60 mg capsules, a cardiovascular drug. The contract has a completion date of June 23, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $5,034.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.20 firm fixed-price contract is for the delivery of 4,568,239,286 units of the medication propranolol ER 60 mg capsule. The contract has a performance period through May 15, 2025 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Propranolol 10 mg tablets in quantities of 100, with a ceiling value of $1,088.55 and a firm fixed price structure. This non-set-aside competitive award is set for ultimate completion on September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,229.72 firm-fixed-price contract is for the delivery of 100 counts of 60 mg Propranolol ER capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for DLA Troop Support Medical through December...
- SPE2DB24D6038Indefinite Delivery Contract
- SPE2DB24D6038-SPE2DB25FEMNJDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Propranolol ER 60 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $4,082.40, represents a non-competitive award and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills a significant role in supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The propranolol delivery addresses the Defense Health Agency's pharmaceutical supply requirements for cardiovascular and related therapeutic applications. AmerisourceBergen's extensive portfolio of competitively awarded contracts with DLA demonstrates the company's capability to manage diverse pharmaceutical and medical supply deliveries across multiple therapeutic domains. The company's established IDC relationship positions it as a key provider for federal healthcare operations and military medical readiness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/15/25 |